Emergent BioSolutions Inc

23 set 2026, 20:07 UTC

Emergent BioSolutions Inc shares fell sharply as inflation concerns and higher bond yields pressured equities, despite strong recent growth in the U.S. private sector.

22 set 2026, 19:51 UTC

Emergent BioSolutions Inc is advancing, currently trading around a 3% cumulative return, well above its 20-day moving average and near the upper end of its one-month range.

21 set 2026, 20:02 UTC

Emergent BioSolutions Inc shares fell sharply after an early high, continuing a decline since Friday amid a broader market backdrop.

18 set 2026, 19:46 UTC

Emergent BioSolutions Inc shares fell sharply, nearing their lowest point of the day after pulling back from an early morning high.

17 set 2026, 20:13 UTC

Emergent BioSolutions Inc. is declining in after-market trading, following a lower close on Thursday, but remains above its 20-day moving average.

16 set 2026, 20:07 UTC

Emergent BioSolutions Inc shares are significantly higher, maintaining strong performance from Tuesday, despite pulling back slightly after reaching a midday high.

15 set 2026, 19:16 UTC

Emergent BioSolutions Inc shares are lower as the company cuts 90 jobs and restructures to save $40 million amid rising treasury yields and inflation concerns.

11 set 2026, 20:01 UTC

Emergent BioSolutions Inc shares are higher, following a recent decline in the Michigan Consumer Sentiment Index, which fell to 47.8, below expectations.

10 set 2026, 20:03 UTC

Emergent BioSolutions shares are higher today, supported by a consensus "Hold" rating and reaffirmed buy ratings from UBS and Benchmark. The average target price is $10.00.

9 set 2026, 20:02 UTC

Emergent BioSolutions Inc shares are lower today, continuing a decline since Tuesday's close. No specific news was identified to explain the movement.

8 set 2026, 20:08 UTC

Emergent BioSolutions Inc shares are lower following a downgrade to Hold amid concerns over declining revenues and ongoing debt issues.

3 set 2026, 20:03 UTC

Emergent BioSolutions faces investigation amid $191.3 million impairment charge and $180.2 million net loss, contributing to shares trading lower today.

2 set 2026, 19:53 UTC

Emergent BioSolutions Inc. is under investigation related to recent financial disclosures, following a significant net loss and reduced revenue guidance. Shares are higher today.

1 set 2026, 20:09 UTC

Emergent BioSolutions secures a $24 million contract modification from BARDA for its anthrax vaccine, CYFENDUS®, as shares rise in Tuesday trading.

31 ago 2026, 20:02 UTC

Emergent BioSolutions secures a Canadian government contract for NARCAN® Nasal Spray, boosting shares during Monday's session. The agreement runs from October 2026 to September 2029.

28 ago 2026, 20:07 UTC

Emergent BioSolutions shares are lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC, following a $191.3 million impairment charge and reduced revenue guidance.

27 ago 2026, 20:07 UTC

Emergent BioSolutions Inc. is under investigation, following a $180.2 million net loss and reduced revenue guidance, contributing to a decline in shares today.

26 ago 2026, 20:08 UTC

Emergent BioSolutions Inc shares are higher, reflecting strong upward momentum since Tuesday. The stock remains well above its 20-day moving average.

25 ago 2026, 20:07 UTC

Emergent BioSolutions Inc shares are higher during Tuesday's session, continuing a strong advance since Monday's close amid easing Treasury yields and lower oil prices.

24 ago 2026, 19:51 UTC

Emergent BioSolutions Inc shares are higher today, continuing a cumulative increase since Friday. The stock remains below its 20-day moving average.

21 ago 2026, 19:51 UTC

Emergent BioSolutions Inc shares are higher today, continuing a steady upward trend since Thursday's close. No specific news was identified to explain the movement.

20 ago 2026, 19:02 UTC

Emergent BioSolutions Inc faces scrutiny after a $191.3 million impairment charge and a reduced revenue outlook, contributing to a decline in shares.

19 ago 2026, 19:52 UTC

Emergent BioSolutions Inc is trading higher during Wednesday's session, recovering from earlier lows and reflecting strength since Tuesday's close. No specific news was identified.

18 ago 2026, 20:06 UTC

Emergent BioSolutions Inc shares are higher today, reflecting a broader market recovery. The stock remains below its 20-day moving average and prior month levels.

17 ago 2026, 19:56 UTC

Emergent BioSolutions faces investigations over financial disclosures, including a $191.3 million impairment charge, contributing to lower shares amid declining investor confidence.

13 ago 2026, 19:51 UTC

Emergent BioSolutions Inc shares are roughly flat as jobless claims rise to 209,000, exceeding expectations. The stock remains below its 20-day moving average.

12 ago 2026, 19:26 UTC

Emergent BioSolutions Inc gains amid broader market optimism following inflation data. The stock reached a session high before slightly pulling back.

11 ago 2026, 22:56 UTC

Emergent BioSolutions Inc shares are trading lower in after-market hours. No specific news was identified to explain the movement.

10 ago 2026, 19:51 UTC

Emergent BioSolutions shares are trading lower as H.C. Wainwright reduced its price target to $10.00, citing concerns over performance and outlook amid competitive pressures.

7 ago 2026, 23:26 UTC

Emergent BioSolutions Inc shares rose in after-market trading, amid positive market sentiment and notable gains in major tech stocks. No specific news was identified.